David A. Siegel Sensus Healthcare, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,800 shares of SRTS stock, worth $49,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,800
Previous 85,600
87.38%
Holding current value
$49,679
Previous $496,000
85.28%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SRTS
# of Institutions
70Shares Held
4.9MCall Options Held
31.2KPut Options Held
2.1K-
Vanguard Group Inc Valley Forge, PA740KShares$3.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny431KShares$1.98 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX379KShares$1.74 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA348KShares$1.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY249KShares$1.15 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $76.2M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...